You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Attention Score in Context
| Title |
Anti-infliximab antibodies are already detectable in most patients with rheumatoid arthritis halfway through an infusioncycle: an open-label pharmacokinetic cohort study
|
|---|---|
| Published in |
BMC Musculoskeletal Disorders, January 2011
|
| DOI | 10.1186/1471-2474-12-12 |
| Pubmed ID | |
| Authors |
Bart JF van den Bemt, Alfons A den Broeder, GJ Wolbink, Yechiel A Hekster, Piet LCM van Riel, Bart Benraad, Frank HJ van den Hoogen |
| Abstract |
This study in patients with rheumatoid arthritis (RA) treated with infliximab describes prospectively the course of (anti)infliximab levels within an infusion cycle to assess at what moment patients develop low/no infliximab trough levels and/or detectable anti-infliximab levels. |
Mendeley readers
The data shown below were compiled from readership statistics for 58 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 58 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 15 | 26% |
| Researcher | 13 | 22% |
| Professor | 6 | 10% |
| Student > Master | 5 | 9% |
| Professor > Associate Professor | 3 | 5% |
| Other | 5 | 9% |
| Unknown | 11 | 19% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 16 | 28% |
| Agricultural and Biological Sciences | 15 | 26% |
| Pharmacology, Toxicology and Pharmaceutical Science | 6 | 10% |
| Immunology and Microbiology | 4 | 7% |
| Biochemistry, Genetics and Molecular Biology | 1 | 2% |
| Other | 5 | 9% |
| Unknown | 11 | 19% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 January 2011.
All research outputs
#20,148,663
of 22,655,397 outputs
Outputs from BMC Musculoskeletal Disorders
#3,605
of 4,023 outputs
Outputs of similar age
#170,418
of 180,975 outputs
Outputs of similar age from BMC Musculoskeletal Disorders
#22
of 23 outputs
Altmetric has tracked 22,655,397 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,023 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.0. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 180,975 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 23 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.